Previous 10 | Next 10 |
Thorofare, New Jersey, May 14, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that Premas Biotech, its partner in the development of a vaccine candidate that is seeking to a...
Applied DNA Sciences (NASDAQ: APDN ) +71% after receiving FDA emergency use authorization for COVID-19 test. More news on: Applied DNA Sciences, Inc., AIM ImmunoTech Inc., Immunic, Inc., Stocks on the move, , Read more ...
The FDA has authorized AIM ImmunoTech (NYSEMKT: AIM ) the first human trial assessing the safety and effectiveness of Ampligen (rintatolimod), in combination with interferon alfa-2b, in cancer patients with COVID-19. More news on: AIM ImmunoTech Inc., Healthcare stocks news, Stocks on th...
AIM ImmunoTech (NYSEMKT: AIM ): Q1 GAAP EPS of -$0.22 misses by $0.12 . More news on: AIM ImmunoTech Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
Ended the First Quarter of 2020 with Cash, Cash Equivalents and Marketable Securities of $31.1 Million OCALA, FL / ACCESSWIRE / May 14, 2020 / AIM ImmunoTech (NYSE American:AIM) today announced that the U.S. Food and Drug Administration has authorized the first human trial assessin...
LONDON, May 14, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it has received written comments from the U.S. Food and Drug Administration (FDA) ...
AIM & TSX: “TGL” & NASDAQ: “TGA” CALGARY, Alberta, May 14, 2020 (GLOBE NEWSWIRE) -- TransGlobe Energy Corporation (“TransGlobe” or the “Company”) announces its AGM voting results. Report in Respect of Voting...
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. NEW YORK and LONDON, May 14, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company focused ...
NICOSIA, CYPRUS / ACCESSWIRE / May 14, 2020 / Atalaya Mining Plc (AIM:ATYM)(TSX:AYM), is pleased to announce its unaudited quarterly results for the three months ended 31 March 2020 ("Q1 2020"), together with the unaudited, condensed, interim consolidated financial statements. The Q1 2020 U...
This Announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 (“MAR”). Upon the publication of this Announcement, this inside information is now considered to be in the public domain. AIM & TSX: “TGL...
News, Short Squeeze, Breakout and More Instantly...
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of new pre-clinical data concerning the company’s drug Ampligen as part of a combinational therapy in the...
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Con...
OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series ...